Market Value9,437,744,027
Total Holdings85
File Date2026-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CTNM / Contineum Therapeutics, Inc.
WVE / Wave Life Sciences Ltd.
FDMT / 4D Molecular Therapeutics, Inc.
HLXC / Helix Acquisition Corp. III
HNGE / Hinge Health, Inc.
IPSC / Century Therapeutics, Inc.
AKTS / Aktis Oncology, Inc.
PALI / Palisade Bio, Inc.
SYRE / Spyre Therapeutics, Inc.
PTN / Palatin Technologies, Inc.
LENZ / LENZ Therapeutics, Inc.
CAPR / Capricor Therapeutics, Inc.
WGS / GeneDx Holdings Corp.
GHRS / GH Research PLC
GLTO / Damora Therapeutics, Inc.
SGP / SpyGlass Pharma, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S
ACET / Adicet Bio, Inc.
EWTX / Edgewise Therapeutics, Inc.
NKTX / Nkarta, Inc.
BNTC / Benitec Biopharma Inc.
MPLT / MapLight Therapeutics, Inc.
GRAL / GRAIL, Inc.
ARTV / Artiva Biotherapeutics, Inc.
PRAX / Praxis Precision Medicines, Inc.
NUVL / Nuvalent, Inc.
VOR / Vor Biopharma Inc.
ACRS / Aclaris Therapeutics, Inc.
MLYS / Mineralys Therapeutics, Inc.
SLDB / Solid Biosciences Inc.
GERN / Geron Corporation
OVID / Ovid Therapeutics Inc.
JBIO / Jade Biosciences, Inc.
LXEO / Lexeo Therapeutics, Inc.
IRON / Disc Medicine, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
EVMN / Evommune, Inc.
TSHA / Taysha Gene Therapies, Inc.
RLMD / Relmada Therapeutics, Inc.
SABS / SAB Biotherapeutics, Inc.
LBRX / LB Pharmaceuticals Inc
TVTX / Travere Therapeutics, Inc.
CCCC / C4 Therapeutics, Inc.
MNPR / Monopar Therapeutics Inc.
MGNX / MacroGenics, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
INSP / Inspire Medical Systems, Inc.
EQ / Equillium, Inc.
TYRA / Tyra Biosciences, Inc.
SPRY / ARS Pharmaceuticals, Inc.
PCSC / Perceptive Capital Solutions Corp
BCAX / Bicara Therapeutics Inc.
WAY / Waystar Holding Corp.
SION / Sionna Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
XNCR / Xencor, Inc.
DRUG / Bright Minds Biosciences Inc.
HOWL / Werewolf Therapeutics, Inc.
DSGN / Design Therapeutics, Inc.
ELYM / Eliem Therapeutics, Inc.
ACRV / Acrivon Therapeutics, Inc.
PEPG / PepGen Inc.
RANI / Rani Therapeutics Holdings, Inc.
STRO / Sutro Biopharma, Inc.
BIOA / BioAge Labs, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
OLMA / Olema Pharmaceuticals, Inc.
RZLT / Rezolute, Inc.
NAMS.W / NewAmsterdam Pharma Company N.V. - Equity Warrant
CRVS / Corvus Pharmaceuticals, Inc.
SEPN / Septerna, Inc.
SRPT / Sarepta Therapeutics, Inc.
ALXO / ALX Oncology Holdings Inc.
AVR / Anteris Technologies Global Corp.
RNA / Atrium Therapeutics, Inc.
AVTX / Avalo Therapeutics, Inc.
ASMB / Assembly Biosciences, Inc.
ACLX / Arcellx, Inc.
CDTX / Cidara Therapeutics, Inc.
BLTE / Belite Bio, Inc - Depositary Receipt (Common Stock)
HCAT / Health Catalyst, Inc.
KIDS / OrthoPediatrics Corp.
MDLN / Medline Inc.
PGNY / Progyny, Inc.
QGEN / Qiagen N.V.
RNA / Atrium Therapeutics, Inc.
OKUR / OnKure Therapeutics, Inc.
IVVD / Invivyd, Inc.
FULC / Fulcrum Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
KPTI / Karyopharm Therapeutics Inc.